Invited commentary: 99mTc-N-NOET imaging for myocardial perfusion: Can it offer more than we already have?

Journal of Nuclear Medicine

Volumn 42, Issue 9, 2001, Pages 1395-1396

  Fagret, D ^a   Ghezzi, C ^a   Vanzetto, G ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM (N ETHOXY N ETHYLDITHIOCARBAMATO)NITRIDO TC 99M; TECHNETIUM 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; MICROSPHERE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M, BIS(N ETHOXY N ETHYLDITHIOCARBAMATO)NITRIDO; TECHNETIUM TC 99M, BIS(N-ETHOXY-N-ETHYLDITHIOCARBAMATO)NITRIDO-; THIOCARBAMIC ACID DERIVATIVE;

CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; IMAGING; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DOG; HEART; HEMODYNAMICS; RABBIT; SCINTISCANNING;

ANIMALS; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; DOGS; HEART; HEMODYNAMIC PROCESSES; HUMANS; MICROSPHERES; ORGANOTECHNETIUM COMPOUNDS; RABBITS; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; THIOCARBAMATES;

EID: 0034856342     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (25)

1. Bis(dithiocarbamato)nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agents
2. 99mTcN-NOET in healthy volunteers
3. Myocardial kinetics of TcN-NOET: A neutral lipophilic complex tracer of regional blood flow
4. The effect of ischemic injury on the cardiac transport of Tc-99m N-NOET in the isolated rabbit heart
5. (201)Tl during dobutamine infusion: Comparison with adenosine stress
6. 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: Comparison to thallium-201 and myocardial blood flow
7. Myocardial perfusion imaging with technetium 99m NOET: Comparison with thallium 201 and coronary angiography
8. 99mTcN-NOET in cardiomyocytes from newborn rats: Calcium channel interaction
9. 99mTc-N-NOET myocardial uptake reflects myocardial blood flow and not viability in dogs with reperfused acute myocardial infarction
10. Technetium-99m hexakis 2-methoxy-isobutyl isonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging
11. Technetium 99m 1,2bis[bis(2-ethoxyethyl)phosphino]ethane: Human biodistribution and safety of a new myocardial perfusion imaging agent
12. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity
13. 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis
14. 99mTc-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of subendocardial infarction
15. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy
16. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
17. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction
18. "False positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: Insights from intravascular sonography studies
19. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy
20. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
21. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
22. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis
23. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
24. 99mTcN-NOET in normal, ischemic-reperfused and membrane-disrupted rat myocardium
25. Subcellular distribution of technetium-99m-TcN-NOET in rat myocardium